Risk of Congestive Heart Failure With Gleevec

Jamie Sheller
Attorney
(866) 735-1102 Ext 475
Posted by Jamie ShellerJuly 25, 2006 1:54 PM

The drug Gleevec is a successful treatment for chronic myelogenous leukemia. However, a study led by Dr. Thomas Force of Thomas Jefferson University in Philadelphia, indicates that the drug may be linked to damage to the heart muscle. According to the study, several patients with normal heart function when starting to take Gleevec, developed congestive heart failure between one and 14 months after beginning treatment. The researchers characterized Gleevec as a "wonderful drug," but believe that patients using the drug should be monitored closely to detect signs of heart failure.

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Philadelphia

InjuryBoard Philadelphia RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Injury Board Philadelphia is brought to you by Sheller, P.C.

Legal Assistance Center

More Info
Sheller, P.C. (866) 735-1102 Ext 475 www.sheller.com
google
Personal Injury Lawyers Serving: Statewide Pennsylvania, Philadelphia, Norristown, Cheltenham, Chester, Drexel Hill, Folsom, Havertown, King of Prussia, Levittown, Radnor, Springfield, Swarthmore, West Chester, Willow Grove
1528 Walnut Street3rd Floor, Philadelphia, Pennsylvania 19102 [ Show Map ]
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address